In July 2023, the Centers for Medicare and Medicaid Services (“CMS”) proposed a final rule to address illegal traditional Medicare rates paid in the 340B Drug Pricing Program from 2018-2022. CMS’ proposal would see CMS pay...more
9/18/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Medicare ,
Medicare Advantage ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B
Court Remands Remedy for Unlawful 340B Rule to HHS -
On January 10, 2023, the DC District Court remanded the issue of how to remedy five years of underpayments to 340B hospitals to the Department of Health and Human...more
1/18/2023
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Dobbs v. Jackson Women’s Health Organization ,
Drug Pricing ,
Health Care Providers ,
Healthcare ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Public Health Emergency ,
Section 340B ,
Teaching Hospitals
HELPFUL HINTS -
Justice Department Reports More Than $8B In Alleged Fraud Related to COVID-19 Relief Programs -
The Washington Post reports, “Since the U.S. government first marshaled its historic economic response...more
3/17/2022
/ Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Infectious Diseases ,
Medicare ,
Surprise Medical Bills ,
Telehealth